Approvals/CIMA-AEMPS/LINAGLIPTINA/METFORMINA PHAROS 2,5 MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

LINAGLIPTINA/METFORMINA PHAROS 2,5 MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Pharos Pharmaceutical Oriented Services Ltd.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: b073cbc5f36d8758
Drug Cima Aemps Name: LINAGLIPTINA/METFORMINA PHAROS 2,5 MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 90207
Holder Company Name: Pharos Pharmaceutical Oriented Services Ltd.
Marketing Company Name: Pharos Pharmaceutical Oriented Services Ltd.
Authorization Date: 2025-05-27
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 2,5 mg/ 1.000 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Pharos Pharmaceutical Oriented Services Ltd.

LINAGLIPTINA

2,5 mg

METFORMINA HIDROCLORURO

1.000 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 27, 2025

Approval ID

b073cbc5f36d8758

Type

Standard